Tolerability of Selective Cyclooxygenase Inhibitor, Celecoxib, in Patients with Analgesic Intolerance

References

• Szczeklik A, Stevenson D D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111(5):913–921. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sanak M, Sampson A P. Biosynthesis of cysteinyl leukotrienes in aspirin-intolerant asthma. Clin Exp Allergy 1999; 29:306–313. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Szczeklik A. Mechanism of aspirin-induced asthma. Allergy 1997; 52(6):613–619. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Çelik G, Bavbek S, Mısırlıgil Z, Melli M. Release of cysteinyl leukotrienes with aspirin stimulation and effect of prostaglandin E2 on this release. Clin Exp Allergy 2001; 31:1615–1622. [CSA]
   PubMed Web of Science ®Google Scholar
• Bavbek S, Çelik G, Ediger D, Mungan D, Demirel Y S, Mısırlıgil Z. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance. J Asthma 1999; 36(8):657–663. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Andri L, Senna G, Betteli C, Givanni S, Scaricabarozzi I, Mezzelani P, Andri G. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy 1994; 72(1):29, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Quaratino D, Romano A, Di Fonso M, Papa G, Perrone M R, D'Ambrosio F P, Venuti A. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2000; 84(16):613–617. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Santiago A V, Gonzales-Morales M A, Guadano E M. Tolerance of nimesulide in NSAID intolerant patients. Allergy 2003; 58(4):367–369. [CSA]
   Google Scholar
• Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 1998; 53(12):1231–1233. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bavbek S, Çelik G, Özer F, Mungan D, Mısırlıgil Z. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drugs-intolerant patients: comparison of nimesulide, meloxicam and rofecoxib. J Asthma 2004; 41:65–68.
   Google Scholar
• Karakaya G, Kalyoncu F. Safety of nimesulide, meloxicam and rofecoxib as alternative analgesics. Allergol Immunopathol 2000; 28(6):319–321. [CSA]
   PubMedGoogle Scholar
• Pacor M L, Di Lorenzo G, Biasi M, Barbagallo M, Correchor R. Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy 2002; 32(3):397–400. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Berges-Gimeno M P, Camacho-Garrido E, Garcia-Rodriguez R M, Alfaya T, Martin Garcia C, Hinojosa M. Rofecoxib safe in NSAI hypersensitivity. Allergy 2001; 56(10):1017–1018. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Quiralte J, San Pedro B S, Florido J F. Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reaction. Ann Allergy Asthma Immunol 2002; 89(1):63–66. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Everts B, Wahrborg P, Hedner T. COX-2 specific inhibitor—the emergence of a new class of analgesic and anti-inflammatory drugs. Clin Rheumatol 2000; 19(5):331–343. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hawkey C J. COX-2 inhibitors. Lancet 1999; 353:307–314. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dahlen B, Szczeklik A, Murray J J, and the Celecoxib in Aspirin-Intolerant Asthma Study Group. Celecoxib in patients with asthma and aspirin intolerance. N Engl J Med 2001; 344(2):142, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Garcia-Rodrigez R M, Hinojosa M, Camacho-Garrido E, Gimeno P B, Garcia C M. Celecoxib, safe in NSAID intolerance. Allergy 2002; 57(11):1085–1086. [CSA]
   PubMedGoogle Scholar
• Woessner K M, Simon R A, Stevenson D D. The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002; 46(8):2201–2206., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Martin-Garcia C, Hinojasa M, Berges P, Camacho E, Garcia-Rodriquez R, Alfaya T. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. J Investig Allergol Clin Immunol 2003; 13(1):20–25. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yoshida S, Ishizaki Y, Onumo K, Shoji T, Nakagawa H, Amayasu H. Selective cyclo-oxygenase 2 inhibitor in patients with asthma. J Allergy Clin Immunol 2000; 106(12):1201–1202. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Boehncke W H, Elshorst-Schmid T, Kleinhans M, Koeberich V, Ludwig R, Kaufmann R. Tolerability of the selective cyclooxygenase inhibitor celecoxib in patients with pseudoallergic reactions to nonsteroidal antiinflammatory drugs. Allergy 2003; 58(suppl):1226
   Google Scholar
• Gyllfors P, Bochenec G, Overholt J, Nizankowska E, Drupka D, Kumlin M, Sheller J, Isakson P C, Merjza F, Lefkowith J B, Dahlen S F, Szczeklik A, Murray J J, Dahlen B. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase-2 selective analgetic drug celecoxib. J Allergy Clin Immunol 2003; 111(5):1116–1121. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ahlbach S, Usadel K H, Kaufmann R, Boehncke W H. The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudoallergic reactions to nonsteroidal anti-inflammatory drugs. Med Klin 2003; 98(5):242–244. [PUBMED], [INFOTRIEVE]
   Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 1987; 136:225–243.
   PubMed Web of Science ®Google Scholar
• Grimm V, Rakoski J, Ring J. Urticaria and angioedema induced by COX-2 inhibitors. J Allergy Clin Immunol 2002; 109(2):370, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Patterson R, Bello A E, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther 1999; 21(12):2065–2079. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Levy M B, Fink J N. Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001; 87(1):72–73. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Grob M, Pichler W J, Wüthrich B. Anaphylaxis to celecoxib. Allergy 2002; 57(3):264–265. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Weber-Mani U, Reimers A, Pichler W J, Muller U. Celecoxib (Celebrex)-induced anaphylaxis. Allergologie 2002; 25(10):534–538.
   Google Scholar
• Gagnon R, Julien M, Gold P. Selective celecoxib-associated anaphylactoid reaction. J Allergy Clin Immunol 2003; 111(6):1404–1405. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bochenek G, Nizankowska E, Szczeklik A. The atopy triat in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 1996; 51:16–23. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Çelik G, Mungan D, Bavbek S, Sin B, Ediger D, Demirel Y, Mısırlıgil Z. The prevalence of allergic diseases and atopy in Ankara, Turkey: a two-step population-based epidemiological study. J Asthma 1999; 36(3):281–290.
   PubMed Web of Science ®Google Scholar
• Çelik G, Mungan D, Özer F, Ediger D, Bavbek S, Sin B, Demirel Y S, Mısırlıgil Z. Clinical features and atopy profile in Turkish subjects with analgesic intolerance. J Asthma 2002; 39(2):101–106.
   PubMed Web of Science ®Google Scholar
• Stevenson D D, Simon R A. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton E, Reed C E, Ellis E F, Adkinson N F, Yunginger J W, Busse W W, eds. Allergy, Principles and Practice. St. Louis: Mosby-Year Book, 1993:1747–1765.
   Google Scholar
• Papa G, Romano A, Del Bono A, Guiseppe P, Antonino R, Alessandro D B, Donato Q, Marino D F, Donatella P, Franceska G, Alberto V. Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 1997; 78:74–78. [CSA]
   PubMedGoogle Scholar
• Ispano M, Fontana A, Scibilia J, Ortolani C. Oral challenge with alternative nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drug 1993; 46(suppl 1):253–256.
   PubMedGoogle Scholar